St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive ...

China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease: London, UK Friday, February 21, 2025, 09:00 Hrs [IST] GSK plc announ ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...

GSK (GSK) announced that the China National Medical Products Administration, CNMPA, has accepted for review the new drug application for the ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

COPD treatment goal is to help you breathe easier ... When you have moderate to severe disease, you and your doctor will work together to find the right therapy for you. Although there's no ...

Researchers have found in a phase 3 trials that Dupilumab significantly reduced moderate or severe COPD exacerbations ...

This is the first major breakthrough in 50 years. British researchers have just discovered a new treatment for severe forms of asthma. At the time of the attack, the treatment consists of an injection ...

Columnist Caroline Gainer discusses a study whose findings suggested that respiratory muscle strength training could help ...